Latest articles

EURACTIV - Benoît van den Hove tells Euractiv that scaling biotech companies at a global level still depends on capital that Europe does not yet mobilise at sufficient scale. Read more

APM MARKET ACCESS - The European Council and the European Parliament have reached a provisional agreement on implementing tariff elements of the EU-U.S. Joint Statement, as pharmaceutical industry groups warn that continued uncertainty around transatlantic trade could disrupt drug supply chains and increase pressure on smaller innovative companies....

EURACTIV - Healthcare is increasingly being asked to square a difficult circle: deliver care without contributing to the environmental pressures driving disease in the first place. At the same time, systems are being pushed to shift from treatment to prevention as the basis for long-term sustainability. Read more

EU PERSPECTIVES - Europe prides itself on universal healthcare, yet patients still wait hundreds of days—sometimes even years—for access to new medicines. EU Health Commissioner Olivér Várhelyi is openly warning that without faster approvals, quicker reimbursement decisions and stronger pharmaceutical production in Europe, the continent's...